Rebecca Lin
Direktor/Vorstandsmitglied bei Shanghai Rarestone Health Tech Group Co. Ltd.
Profil
Rebecca Lin is currently the Director at Shanghai Rarestone Health Tech Group Co. Ltd.
and the Senior Partner at Eight Roads Capital Advisors (CHINA).
She completed her undergraduate degree at Shenzhen University in 1994 and obtained an MBA from The Wharton School of the University of Pennsylvania in 2000.
Aktive Positionen von Rebecca Lin
| Unternehmen | Position | Beginn |
|---|---|---|
| Eight Roads Capital Advisors (CHINA) | Private Equity Investor | 01.01.2021 |
Shanghai Rarestone Health Tech Group Co. Ltd.
 Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Rarestone Health Tech Group Co. Ltd. is a Chinese company that focuses on rare disease therapy and self-management information through internet information. The company is based in Huangpu, China. The company also operates and promote medical devices and communication platforms. The CEO of the company is Shawn Xiang. | Direktor/Vorstandsmitglied | - |
Ausbildung von Rebecca Lin
| Shenzhen University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
| Eight Roads Capital Advisors (CHINA) | Finance |
Shanghai Rarestone Health Tech Group Co. Ltd.
Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Rarestone Health Tech Group Co. Ltd. is a Chinese company that focuses on rare disease therapy and self-management information through internet information. The company is based in Huangpu, China. The company also operates and promote medical devices and communication platforms. The CEO of the company is Shawn Xiang. | Health Technology |
